ClinicalTrials.gg
RecruitingNCT07408882ADMITUpdated Feb 18, 2026

Evaluation of an Integrated Home Care Model

An interventional study of ADMIT integrated care Program in Older Adults (70 or More) Living at Home With Health and Social Complexity, sponsored by Parc Sanitari Pere Virgili. Recruiting at 8 sites in Spain. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2026-02-18.

Sponsored by Parc Sanitari Pere Virgili · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Ages
70 Years and older
Sex
All
01

Study summary

The demographic shift towards a progressive aging of the population represents an unprecedented challenge for Western societies and for the sustainability of health and social systems.

Hypotheses: A complex, multi-component intervention based on integrated home care, facilitated by technological tools and focused on the frail person with complex needs (ADMIT Program):

  • Will increase at least 5% of the days spent at home compared to usual care
  • Will reduce exacerbations or health or social crisis at home
  • Will improve the quality of life and well-being of users and their informal caregiver
  • Will improve the experience of the people cared for, their caregivers and professionals in the health and social systems

Main objective: To evaluate the effectiveness of the ADMIT program in increasing the % of days at home of frail elderly people compared to usual practice.

Secondary objectives:

To evaluate the effectiveness of the ADMIT program compared to usual care to reduce exacerbations or situations of crisis that motivate emergency care or hospitalizations.

To evaluate the incremental cost-utility ratio of the ADMIT program in relation to usual practice, exploring different time horizons and different scenarios of population scalability.

To evaluate the experience of the people treated, their informal caregivers and professionals.

To identify the determinants of change and contextual factors of the program implementation process

Methodology:

Hybrid evaluation model that allows evaluating the process, effectiveness, safety and cost-utility while implementing the intervention in real life. Mixed methods, typical of implementation science, will be used, with different stages: First stage: co-creation of the care model and the technological platform with the participation of users and professionals Second stage: evaluation of the process, results and experience through a pragmatic randomized controlled trial with a batched stepped wedge design and comparison with a parallel "external" control group, matched using propensity score techniques.

Applicability and Relevance: The ADMIT program is aligned with the current trend and the shared interest of evolving towards integrated social and health care, keeping people with complex needs in their homes for as long as possible and with the best possible quality of life. The ADMIT project is an implementation project supported by the Catalan Health Department and the Integrated Care Agency. The technological platform that will be co-created and piloted is expected to be adopted by Catalan Health Department for its scaling up in the territory.

02

Conditions studied

  • Older Adults (70 or More) Living at Home With Health and Social Complexity

Keywords

  • integrated care
  • implementation science
  • mixed models
  • hybrid design
03

In context

Lead sponsor

Parc Sanitari Pere Virgili is the lead sponsor of 9 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Living at home AND
  • Adjusted Morbidity Group = 3 or 4 or high risk OR Complex or Advanced frailty or chronicity OR Home health care program; AND
  • Dependent for the basic daily activities OR Social complexity (SSM-CAT positive) OR Dependency grade= 1, 2 or 3 OR Lack of social support OR Home social care program OR Living alone

Exclusion criteria

Exclusion Criteria:

  • Living in a nursing home
  • Unable to make decisions about care (either by the patient or the caregiver)
  • Person with needs that exceed the coverage of the program
  • Not providing
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
1,000 participants (estimated)

Study arms

  • No intervention
    Usual care
  • Experimental
    ADMIT Program

    Other: ADMIT integrated care Program

Interventions

  • OtherADMIT integrated care Program

    Participants will be attended following an integrated care program which is being co-created by professionals, patients and caregivers, with the following principles: 1. Proactive detection of candidates from both sides (the health and the social services); 2. Designation of a reference and a co-reference professional, one from each side; 3. Shared situational diagnosis based on a comprehensive geriatric assessment; 4. Definition of a shared individual care pathway; 5. Shared follow up. Using a tehcnological platform to facilitate sharing of information and communication between all stakeholders. In some instances, sensoric and robotic devices will be used to monitor and support home care

06

What researchers measure

Primary outcomes

  1. Percentage of days at home

    (Follow up days - (Mortality days + Inpatient Days + Nursing home Days + Home Health Visits + Emergency Department Visits + Inpatient Psychiatry Days + Inpatient Rehabilitation Days + Long term Hospital Days))/follow up days \*100

    Time frame: During the intervention (6 months from the baseline).

07

Study locations

6 of 8 sites recruiting
  • CAP Larrard
    Barcelona, Barcelona 08041, Spain
    Recruiting
  • CAP Sarrià
    Barcelona, Barcelona 08041, Spain
    Recruiting
  • EBA Vallcarca
    Barcelona, Spain
    Recruiting
  • Institut Municipal de Serveis Socials - Ajuntament de Barcelona
    Barcelona, Spain
    Recruiting
  • Institut Català de la Salut - Girona
    Girona, Spain
    Recruiting
  • Consorci Acció Social La Garrotxa
    Olot, Spain
    Not yet recruiting
  • Fundació Hospital d'Olot i Comarcal de la Garrotxa
    Olot, Spain
    Recruiting
  • Programa de Gestió d'Atenció a la Complexitat (PGAC)
    Vic, Spain
    Not yet recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2025 (actual). Primary completion is estimated for Oct 2026, 17 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2025
First posted
Feb 13, 2026
StartActual
May 15, 2025
Primary completionEst.
Oct 31, 2026
CompletionEst.
Oct 31, 2026
Last update
Feb 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07408882
Lead sponsor
Parc Sanitari Pere Virgili
Collaborators
CatSalut Catalonia, Spain, AMADIP
Responsible party
Sponsor
First posted
Feb 13, 2026
Start date
May 15, 2025
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Feb 18, 2026

Study contacts

Aida Ribera-Solé, PhD
Contact
ariberas@perevirgili.cat
+34 932594263
Lorena Villa-Garcia, PhD
Contact
lvilla@perevirgili.cat
+34 932594263
Marco Inzitari, PhD
study director · Parc Sanitari Pere Virgili

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion